Inogen, Inc.

Healthcare

NASDAQ:INGN · NASDAQ Global Select

Market Cap $170.57M Beta 1.59 P/E (TTM) -7.0

$6.40 +1.59%

+$0.10 today

52W Low $5.34High $9.13

Vol 0.15M · Avg 0.33M

EPS (TTM)-$0.91

Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+2.40%

Period High

$8.95

Period Low

$5.59

Latest

$6.40

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Shoulder Innovations, Inc.

NYSE:SI

$387.80M

Sight Sciences, Inc.

NASDAQ:SGHT

$279.12M

Perspective Therapeutics, Inc.

AMEX:CATX

$227.89M

Eupraxia Pharmaceuticals Inc.

NASDAQ:EPRX

$202.22M

Quanterix Corporation

NASDAQ:QTRX

$146.03M

Health Catalyst, Inc.

NASDAQ:HCAT

$136.70M

SANUWAVE Health, Inc.

NASDAQ:SNWV

$128.21M

Nano-X Imaging Ltd.

NASDAQ:NNOX

$122.48M

Solana Company

NASDAQ:HSDT

$89.92M

Outset Medical, Inc.

NASDAQ:OM

$83.23M

What is the latest INGN filing?

The latest filing shown is S-8 dated Jun 12, 2026.

How many recent filings does INGN have?

Intrinsic Alpha currently shows 20 recent filings for INGN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.